Back

Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes

1 September 2019 (11:09 - 11:18)
Organised by:
Congress Presentation Part of: Challenges in hypertension treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Susanne Jung

University Hospital Erlangen, Erlangen (Germany)

9 More presentations in this session

Presentation thumbnail
Dose antihypertensive medication improve accelerated age-dependent decline of GFR in hypertension?
Doctor H. Takase (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Effect of sodium glucose cotransporter 2 inhibitor on sympathetic nerve activity in type 2 diabetes mellitus patients
Doctor T. Hamaoka (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Adverse effects of spironolactone in long-term treatment of resistant arterial hypertension
Associate Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
The administration of an aldosterone antagonist as the second step of treatment improves efficacy and adherence at all hypertensive levels
Doctor V. Martire (La Plata, AR)
Presentation thumbnail
Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials
Doctor D. Vukadinovic (Homburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in hypertension treatment

The Event

Event poster

ESC Congress 2019

1 September 2019 11:09 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Webinar
Management of blood pressure: selected case-based advice
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy in hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources